Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III tri... von Icli, F, Akbulut, H, Uner, A, Yalcin, B, Baltali, E, Altinbas, M, Coşkun, Ş, Komurcu, S, Erkisi, M, Demirkazik, A, Senler, F C, Sencan, O, Büyükcelik, A, Boruban, C, Onur, H, Zengin, N, Sak, S D

Volltext

ABO and Rh blood groups frequency in women with HER2 positive breast cancer von Urun, Y, Utkan, G, Altundag, K, Arslan, O, Onur, H, Arslan, U Y, Kocer, M, Dogan, I, Senler, F C, Yalcin, B, Demirkazik, A, Akbulut, H, Icli, F

Volltext

The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma von SENCAN, O., BUYUKCELIK, A., YALCIN, B., BORUBAN, M.C., AKBULUT, H., DEMIRKAZIK, A., SENLER, F.C., ONUR, H., ICLI, F.

Volltext

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer von Ürun, Y, Utkan, G, Yalcin, B, Akbulut, H, Onur, H, Oztuna, D G, Şenler, F C, Demirkazık, A, İçli, F

Volltext

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte‐macrophage–colony stimulating factor in patients with soft tissue... von Dinçol, Dilek, Samur, Mustafa, Pamir, Ali, Şencan, Orhan, Akbulut, Hakan, Yalçın, Bülent, Onur, Handan, Demirkazık, Ahmet, Şenler, Filiz Çay, İçli, Fikri

Volltext

P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients von Peled, N., Gillis, R., Kilickap, S., Froesch, P., Orlov, S., Filippova, E., Demirci, U., Christopoulos, P., Cicin, I., Bugdayci Basal, F., Yilmaz, C., Fedor, M., Korkmaz, T., Paydas, S., Gautschi, O., Zirtiloglu, A., Eralp, Y., Cinkir, H.Y., Sezer, A., Erman, M., Tural, D., Turna, H.Z., Mazieres, J., Dudnik, E., Reguart, N., Camidge, R., Ng, T.L., Senler, F. Cay, Beypınar, İ., Yazılıtaş, D., Demirkazik, A., Karaoğlu, A., Okutur, K., Şenol Coşkun, H., Nahit Şendur, M.A., Isikdogan, A., Cabuk, D., Yumuk, P.F., Yıldız, I., Kaplan, M.A., Özyılkan, Ö., Öztop, İ., Olmez, O.F., Aydin, K., Aydıner, A., Meydan, N., Grinberg, R., Roisman, L.

Volltext

P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey von Kilickap, S., Demirci, U., Bugdayci, F., Tural, D., Korkmaz, T., Paydas, S., Yilmaz, C., Turna, H., Sezer, A., Cinkir, H. Yesil, Okutur, K., Erman, M., Eralp, Y., Cabuk, D., Isikdogan, A., Demirkazik, A., Karaoglu, A., Yazilitas, D., Senler, F. Cay, Yumuk, P.F., Coskun, H., Yildiz, I., Oztop, I., Beypinar, I., Aydin, K., Kaplan, M., Meydan, N., Olmez, O.F., Ozyilkan, O., Seber, S., Arslan, C., Sendur, M.A., Cicin, I.

Volltext

9067 POSTER The Significance of the Serum Leptin, Ghreline, Tumour Necrosis Factor Alpha and lnterleukine-1 Levels in Patients With Non-Small Cell Lung Cancer von Urun, Y, Yalcin, B, Karatas, F, Utkan, G, Yuksel, C, Cangir, A.K, Senler, F.C, Demirkazik, A, Akbulut, H, Icli, F, Sencan, O

Volltext

1617PDWorse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncolo... von Alkan, A, Yaşar, A, Güç, Z G, Gürbüz, M, Başoğlu, T, Sezgin Göksu, S, Buğdaycı Başal, F, Türk, H M, Özdemir, Ö, Yeşil Çınkır, H, Güven, D C, Kuş, T, Türker, S, Koral, L, Karakaş, Y, Ak, N, Paydaş, S, Karcı, E, Tanrıverdi, Ö, Çay Şenler, F

Volltext

Prediction of antihypertensive response to intervention in patients with renal artery stenosis (RAS) von Barri, Y, Wilcox, CS, Davidson, R, Senler, S, Hawkins, IF

Volltext